Monday, October 27, 2008

FDA Finds It Hard To Inspect Foreign Drug Manufacturing Plants

The numbers are pretty startling. It seems as though the FDA doesn't inspect domestic drug plants too often, but worse, they inspect foreign plants even less. Get the complete details in this Chicago Tribune news article, "FDA scrutiny of foreign drug plants knocked - GAO report finds huge gap in inspections." Here are some quick highlights . . .

  1. Pharmaceutical factories in the U.S. get a federal inspection every 2.7 years, on average
  2. It would take U.S. inspectors 13 years to visit each of the 3,249 foreign manufacturing plants that make medications for the American market
  3. The GAO (Government Accountability Office) recommended more surveillance inspections of foreign plants

Return Home: http://drughealth.blogspot.com/
Return to Mobile Home: http://drughealth.mofuse.mobi/

No comments:

From SkillsPlus International Inc.

Custom Search

Even More Resources, Books, & Things (many from Amazon.com)

FDA, GMPs, QSR, GCP, GLP, GXP:
    GMP Training Gifts & Giveaways